Early Onset Breast Cancer is on the Rise in Younger Women
Data from recent years shows that early onset breast cancer is on the rise, particularly in younger women under age 50. The breast cancer incidence rate is increasing at 1.4 percent annually in those under the age of 50, compared to 0.7 percent for women over the age of 50.1 While breast cancer incidence in […]
Popular Cold Medicine Contains Cancer-Causing Benzene
According to a recent analysis by Bloomberg, generic store-brand versions of Mucinex, a popular cold medicine containing guaifenesin that is used by millions of Americans during cold and flu season, have been found to contain benzene. A cancer-causing chemical linked to leukemia and other serious blood disorders, benzene is the same carcinogenic compound found in […]
Top Killers in America
A study published in 2016 in the British Medical Journal (BMJ) identified “medical error” as the third leading cause of death in the United States. Study authors reported that medical errors are responsible for the deaths of about 251,000 Americans each year—up from the nearly 100,000 Americans estimated by the Institute of Medicine (IOM) in […]
Novel Breast Cancer Vaccine Technology Receives Japanese Patent
Anixa Biosciences, Inc. of San Jose, California announced on July 17, 2024, that its collaborator, the Cleveland Clinic, has received a “Decision to Grant” notice from the Japan Patent Office (JPO) for the patent application titled “Vaccine Adjuvants and Formulations” for its novel breast cancer vaccine technology. The company is two decades into developing a […]
Sperm Samples in French Infertility Clinic Have High Levels of Glyphosate
A recent study published in The Journal of Ecotoxicology and Environmental Safety last month revealed that more than half of the sperm samples collected from the Pole Santé Leonard de Vinci infertility clinic near Tours, France contained high levels of glyphosate—the primary ingredient in Bayer AG’s Roundup weed killer, which was developed and formerly marketed […]
Multiple Dana-Farber Cancer Institute Studies Retracted After Data Manipulation Detected
The reputation of the prestigious Harvard University-affiliated Dana-Farber Cancer Institute (DFCI) in Boston, Massachusetts is at stake after seven studies were retracted from the medical literature and over 30 papers were subject to corrections due to errors. The allegations, which involve image duplications and manipulations in biomedical research, first surfaced in January 2024 when microbiologist […]